NCT05339438

Brief Summary

Anterior temporal epilepsy is the most frequent form of focal epilepsy (more than 50% of focal epilepsies). The epilepsy is drug-resistant when epileptic seizures persist despite antiepileptic treatment (25% of cases). In this case, it is possible to offer a surgical solution to the patient: an anterior temporal lobectomy. This surgery consists of removing the entire portion of the temporal lobe responsible for epilepsy (epileptogenic zone), that is to say a major part of the temporal pole, the hippocampus and the ventral anterior temporal lobe (vATL). The goal of the surgery is to lead to a disappearance of the seizures while preserving the functions of the patient. This is why a pre-surgical assessment is systematically carried out in order to locate the epileptic focus and to predict the risks of neurological and cognitive deficits. The vATL is of particular interest because it is a highly functional region, involved in naming, semantic processing and face recognition. A resection of this region by anterior lobectomy can therefore impact these functions and lead to cognitive deficits (for example, up to 65% decline in naming), which can be disabling in the lives of patients, even if they are free from seizures. One of the major challenges of epilepsy surgery is therefore to predict the postoperative neuropsychological outcome. The prediction of the neuropsychological outcome of the post-surgery patient is largely based on the mapping of functional regions preoperatively, carried out by functional MRI (fMRI), or by electrical stimulation carried out during intracerebral exploration by StereoElectroEncephalography (SEEG). However, current techniques have drawbacks. Electrical stimulations are based on an invasive exploration (SEEG), are time-consuming and sometimes difficult to interpret. The fMRI sequences used in clinical routine do not make it possible to visualize the entire vATL region because of artifacts related to the auditory canal. Thus, the signal is strongly diminished in this region, rendering a large area of the vATL invisible. This results in insufficient visualization of activated vATL regions when performing tasks such as naming, semantic processing, and face recognition. Important functional regions can therefore be removed during surgery and negatively impact the patient's neuropsychological outcome. In the CARTA study, original methods are associated in order to increase the signal-to-noise ratio in vATL. On the one hand, the Multi-Band sequence, an innovative fMRI sequence, will be used. On the other hand, a particular method of presentation of visual stimuli will be used, called fast periodic visual stimulation (FPVS: Fast Periodic Visual Stimulation), during which the stimuli are presented periodically (fixed frequency). Individually, these methods improve vATL (signal enhancement) exploration. The investigators assume that the combination of the two methods may have a potentiating effect, compared to the standard SMS (Simultaneous Multi-Slice) sequence. fMRI exploration will not influence the surgical management of the patient included in the study because it is the beginning of the development of this technique, but could be used, in the longer term, to guide the surgeries of epileptic patients. Thus, the goal of this study is to precisely map the vATL, using innovative methods in fMRI. This mapping will make it possible to study the cerebral functions of the vATL involved in naming, semantic processing and face recognition, and ultimately improve the postoperative neuropsychological prognosis of epileptic patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Jun 2022Jun 2027

First Submitted

Initial submission to the registry

April 6, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 21, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

June 10, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2027

Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

5 years

First QC Date

April 6, 2022

Last Update Submit

June 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional Anterior Temporal Lobe activity

    Blood Oxygen Level Dependent (BOLD) measures for each task (naming, semantic processing, and face recognition)

    3 years

Study Arms (2)

Epileptic patients

EXPERIMENTAL

Epileptic patients with anterior temporal lobe epilepsy

Radiation: functional MRI

Healthy volunteers

EXPERIMENTAL

Healthy volunteers

Radiation: functional MRI

Interventions

Functional MRI scanning (around 1h30 min): SMS + multi-band (with FPVS paradigms for both)

Epileptic patientsHealthy volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult person,
  • Person affiliated to a social security scheme or beneficiary of such a scheme,
  • Person having received complete information on the organization of the Clinical Investigation and having signed informed consent,
  • Person having carried out a preliminary clinical examination adapted to the Clinical Investigation,
  • For patients: Person with drug-resistant structural focal epilepsy of the anterior temporal lobe (right or left), candidate for epilepsy surgery (anterior temporal lobectomy),
  • For healthy volunteers: Person with no known pathology in the anterior temporal lobe (particularly epilepsy).

You may not qualify if:

  • Contraindication to MRI including claustrophobia,
  • Uncorrected visual disturbances,
  • Person unable to give consent,
  • Lack of mastery of the French language or ability to understand instructions,
  • Person referred to in Articles 64, 65 and 66 of European Regulation 2017/745: Person of full age unable to consent alone to participate in the Clinical Investigation; Minor; Pregnant or breastfeeding woman.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Régional Universitaire de Nancy

Nancy, France

RECRUITING

Related Publications (5)

  • Visser M, Lambon Ralph MA. Differential contributions of bilateral ventral anterior temporal lobe and left anterior superior temporal gyrus to semantic processes. J Cogn Neurosci. 2011 Oct;23(10):3121-31. doi: 10.1162/jocn_a_00007. Epub 2011 Mar 10.

  • Jonas J, Jacques C, Liu-Shuang J, Brissart H, Colnat-Coulbois S, Maillard L, Rossion B. A face-selective ventral occipito-temporal map of the human brain with intracerebral potentials. Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4088-97. doi: 10.1073/pnas.1522033113. Epub 2016 Jun 27.

  • Jonas J, Rossion B, Brissart H, Frismand S, Jacques C, Hossu G, Colnat-Coulbois S, Vespignani H, Vignal JP, Maillard L. Beyond the core face-processing network: Intracerebral stimulation of a face-selective area in the right anterior fusiform gyrus elicits transient prosopagnosia. Cortex. 2015 Nov;72:140-155. doi: 10.1016/j.cortex.2015.05.026. Epub 2015 Jun 4.

  • Puckett AM, Bollmann S, Poser BA, Palmer J, Barth M, Cunnington R. Using multi-echo simultaneous multi-slice (SMS) EPI to improve functional MRI of the subcortical nuclei of the basal ganglia at ultra-high field (7T). Neuroimage. 2018 May 15;172:886-895. doi: 10.1016/j.neuroimage.2017.12.005. Epub 2017 Dec 5.

  • Gao X, Gentile F, Rossion B. Fast periodic stimulation (FPS): a highly effective approach in fMRI brain mapping. Brain Struct Funct. 2018 Jun;223(5):2433-2454. doi: 10.1007/s00429-018-1630-4. Epub 2018 Mar 3.

MeSH Terms

Conditions

Epilepsy, Temporal LobeCognitive Dysfunction

Condition Hierarchy (Ancestors)

Epilepsies, PartialEpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEpileptic SyndromesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, neurologist

Study Record Dates

First Submitted

April 6, 2022

First Posted

April 21, 2022

Study Start

June 10, 2022

Primary Completion (Estimated)

June 9, 2027

Study Completion (Estimated)

June 9, 2027

Last Updated

July 1, 2025

Record last verified: 2025-06

Locations